Citation: Zhihui ZONG, Zijie ZHAO, Lei HUANG, Zhicheng PAN, Shan WANG, Lili LIANG, Huaqing LIU, Enli ZHANG. Synthesis, crystal structures, and antitumor activity of two metal complexes of imidazolyl acylhydrazones[J]. Chinese Journal of Inorganic Chemistry, ;2026, 42(5): 1048-1062. doi: 10.11862/CJIC.20250330 shu

Synthesis, crystal structures, and antitumor activity of two metal complexes of imidazolyl acylhydrazones

Figures(12)

  • Two complexes [Cd(L)(CH3O)(CH3COO)]·CH3OH·(CH3)2NH (C1) and [Mn(L)Cl2(CH3OH)] (C2) were synthesized by reacting a new imidazole-bearing ligand 4-(1H-imidazol-1-yl)-N′-(pyridin-2-ylmethylene)benzohydrazide (L) with cadmium and manganese salts, respectively. The ligand was characterized by 1H NMR and 13C NMR spectroscopy, while the complexes were analyzed by single-crystal X-ray diffraction, powder X-ray diffraction, thermogravimetric analyses, and UV-Vis spectroscopy. Complex C1 features a 1D zigzag chain structure formed by alternating connections of one ligand and one metal ion. In contrast, complex C2 exhibits a mononuclear molecular structure, where each unit consists of one ligand connected to one manganese ion. Both complexes further form a 3D structure through π-π interactions and intermolecular hydrogen bonds. Cell proliferation assays conducted on four tumor cell lines and one normal cell line revealed that both C1 and C2 exhibited significantly stronger inhibition of tumor cell growth compared to the ligand L. Notably, C1 demonstrated superior anti-proliferative activity against A549 and A2780 cells relative to cisplatin, while showing comparable cytotoxicity toward SMMC-7721 cells. Further mechanistic studies indicated that C1 induces apoptosis in both SMMC-7721 and A549 tumor cells, suppresses the invasion and migration of SMMC-7721 cells, and arrests the cell cycle at the G0/G1 phase.
  • 加载中
    1. [1]

      SUNG H, FERLAY J, SIEGEL R L, LAVERSANNE M, SOERJOMATARAM I, JEMAL A, BRAY F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J. Clin., 2021, 71(3): 209-249

    2. [2]

      KOCARNIK J M, COMPTON K, DEAN F E, FU W, GAW B L, HARVEY J D, HENRIKSON H J, LU D, PENNINI A, XU R. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: A systematic analysis for the global burden of disease study 2019[J]. JAMA Oncol., 2022, 8(3): 420-444  doi: 10.1001/jamaoncol.2021.6987

    3. [3]

      NIERENGARTEN M B. Global cancer statistics 2022: The report offers a view on disparities in the incidence and mortality of cancer by sex and region worldwide and on the areas needing attention[J]. Cancer, 2024, 130(15): 2568  doi: 10.1002/cncr.35444

    4. [4]

      PIRKER R. Chemotherapy remains a cornerstone in the treatment of nonsmall cell lung cancer[J]. Curr. Opin. Oncol., 2020, 32(1): 63-67  doi: 10.1097/CCO.0000000000000592

    5. [5]

      KOLODNY G M. New approach to acquired drug resistance and toxicity in cancer chemotherapy[J]. Med. Hypotheses, 2024, 184: 111293  doi: 10.1016/j.mehy.2024.111293

    6. [6]

      HOLOHAN C, VAN SCHAEYBROECK S, LONGLEY D B, JOHNSTON P G. Cancer drug resistance: An evolving paradigm[J]. Nat. Rev. Cancer, 2013, 13(10): 714-726  doi: 10.1038/nrc3599

    7. [7]

      DILRUBA S, KALAYDA G V. Platinum-based drugs: Past, present and future[J]. Cancer Chemother. Pharmacol., 2016, 77(6): 1103-1124  doi: 10.1007/s00280-016-2976-z

    8. [8]

      WANG W K, YANG F Y, ZHANG L P, WANG M S, YIN L, DONG X Y, XIAO H H, XING N Z. Targeting DNA damage and repair machinery via delivering WEE1 inhibitor and platinum(Ⅳ) prodrugs to stimulate STING pathway for maximizing chemo-immunotherapy in bladder cancer[J]. Adv. Mater., 2024, 36(1): 2308762  doi: 10.1002/adma.202308762

    9. [9]

      BERNAL G, AQUEA G, RAMÍREZ-RIVERA S. Metal-based molecules in the treatment of cancer: From bench to bedside[J]. Oncol. Res., 2025, 33(4): 759  doi: 10.32604/or.2024.057019

    10. [10]

      WANG X, YANG W F, WANG L L, ZHENG L W, CHOI W S. Platinum-based chemotherapy induces demyelination of Schwann cells in oral squamous cell carcinoma treatment[J]. Toxicol. Appl. Pharmacol., 2023, 481: 116751  doi: 10.1016/j.taap.2023.116751

    11. [11]

      JIANG X Y, YANG M W, ZHANG W J, SHI D N, LI Y, HE L X, HUANG S M, CHEN B Y, CHEN X W, KONG L Z, PAN Y B, DENG P W, WANG R, OUYANG Y, CHEN X F, LI J, LI Z, ZOU H Q, ZHANG Y N, SONG L B. Targeting the SPC25/RIOK1/MYH9 axis to overcome tumor stemness and platinum resistance in epithelial ovarian cancer[J]. Adv. Sci., 2024, 11(47): 2406688  doi: 10.1002/advs.202406688

    12. [12]

      MOCHIDA Y, CABRAL H, MIURA Y, OSADA K, NISHIYAMA N, KATAOKA K. Secondary structure-guided assembly of uniform disk-like polymeric micelles incorporating hydrophobic platinum drugs for improved tumor targeting[J]. Chem. Mater., 2025, 37(7): 2457-2473  doi: 10.1021/acs.chemmater.4c02734

    13. [13]

      GEOHAGEN B C, WEISER D A, LOEB D M, NORDSTROEM L U, LOPACHIN R M. Enolate-forming compounds provide protection from platinum neurotoxicity[J]. Chem. Biol. Interact., 2020, 317: 108961  doi: 10.1016/j.cbi.2020.108961

    14. [14]

      PANDA T R, M M, VAIDYA S P, CHHATAR S, SINHA S, MEHROTRA M, CHAKRABORTY S, GADRE S, DUARI P, RAY P. The power of kinetic inertness in improving platinum anticancer therapy by circumventing resistance and ameliorating nephrotoxicity[J]. Angew. Chem.‒Int. Edit., 2023, 62(38): e202303958  doi: 10.1002/anie.202303958

    15. [15]

      LU E Z, GAREEV I, YUAN C, LIANG Y C, SUN J X, CHEN X, BEYLERLI O, SUFIANOV A, ZHAO S G, YANG G. The mechanisms of current platinum anticancer drug resistance in the glioma[J]. Curr. Pharm. Des., 2022, 28(23): 1863-1869  doi: 10.2174/1381612828666220607105746

    16. [16]

      LI K H, ZHAO Y Y, CHENG H L, YANG J J, CHIEN C Y. Ototoxicity among cisplatin, carboplatin, and oxaliplatin in zebrafish model[J]. Environ. Toxicol., 2024, 39(7): 4058-4065  doi: 10.1002/tox.24285

    17. [17]

      ZHAO T K, MEI D Y, MA J, LIU N, ZHANG Q, YANG Z D, CORREIA I. Anti-tumor and cellular mechanisms of Hf tetra-(8-hydroxyquinolinato) complexes[J]. J. Inorg. Biochem., 2025: 112945

    18. [18]

      LIU W K, GUST R. Update on metal N-heterocyclic carbene complexes as potential anti-tumor metallodrugs[J]. Coord. Chem. Rev., 2016, 329: 191-213  doi: 10.1016/j.ccr.2016.09.004

    19. [19]

      KHAN H Y, PARVEEN S, YOUSUF I, TABASSUM S, ARJMAND F. Metal complexes of NSAIDs as potent anti-tumor chemotherapeutics: Mechanistic insights into cytotoxic activity via multiple pathways primarily by inhibition of COX-1 and COX-2 enzymes[J]. Coord. Chem. Rev., 2022, 453: 214316  doi: 10.1016/j.ccr.2021.214316

    20. [20]

      PENG K, ZHENG Y, XIA W, MAO Z W. Organometallic anti-tumor agents: Targeting from biomolecules to dynamic bioprocesses[J]. Chem. Soc. Rev., 2023, 52(8): 2790-2832  doi: 10.1039/D2CS00757F

    21. [21]

      LI X, ZHANG H C, CAO Z, XIAO H H, WENG C, ZHENG Q F. Mitochondria-targeted and ROS-sensitive main-chain ruthenium polymer overcomes cancer drug resistance[J]. J. Control. Release, 2025, 383: 113840  doi: 10.1016/j.jconrel.2025.113840

    22. [22]

      CAO S Y, XIE Y Q, LU X T, ZHAO Z J, ZHOU F Y, WANG J, LIANG L L. Two multifunctional zero-dimensional Gd(Ⅲ) complexes: Magnetocaloric effect and anticancer mechanisms for lung cancer[J]. J. Inorg. Biochem., 2025, 265: 112832  doi: 10.1016/j.jinorgbio.2025.112832

    23. [23]

      KARGES J. Clinical development of metal complexes as photosensitizers for photodynamic therapy of cancer[J]. Angew. Chem.‒Int. Edit, 2022, 61(5): e202112236  doi: 10.1002/anie.202112236

    24. [24]

      ZHU M S Q, JIN H L, SHAO T, LI Y Y, LIU J, GAN L H, LONG M N. Polysaccharide-based fast self-healing ion gel based on acylhydrazone and metal coordination bonds[J]. Mater. Des., 2020, 192: 108723  doi: 10.1016/j.matdes.2020.108723

    25. [25]

      JIANG T, TIAN L C, HUANG C, ZHU B X, CHEN D M, ZHU C. A new fluorescent chemosensor based on 2, 2′-bipyridyl acylhydrazone Schiff base: Synthesis, sensing properties, and coordination behaviors[J]. Inorg. Chim. Acta, 2023, 547: 121367  doi: 10.1016/j.ica.2022.121367

    26. [26]

      WANG K, GAO S, LUO Y Z, YAO Z J. Synthesis and catalytic activity of half-sandwich iridium complexes with acylhydrazone ligands for N-alkylation of hydrazides under mild conditions[J]. Appl. Organomet. Chem., 2024, 38(6): e7473  doi: 10.1002/aoc.7473

    27. [27]

      CHANG Q H, XIE Y Q, LU X T, ZONG Z H, ZHANG E L, CAO S Y, LIANG L L. In vitro and in vivo antiproliferative activity on lung cancer of two acylhydrazone based zinc(Ⅱ) complexes[J]. Bioorg. Chem., 2024, 147: 107422  doi: 10.1016/j.bioorg.2024.107422

    28. [28]

      YANG W Z, WEN J, LIU X C, LIU J F. Preparation of ferrocene-iridium(Ⅲ) acylhydrazone complexes and their anticancer application against A549 cell line[J]. J. Inorg. Biochem., 2025, 269: 112899  doi: 10.1016/j.jinorgbio.2025.112899

    29. [29]

      SANTA MARIA DE LA PARRA L, ROMO A I B, RODRIGUEZ-LOPEZ J, NASCIMENTO O R, ECHEVERRIA G A, PIRO O E, LEON I E. Promising dual anticancer and antimetastatic action by a Cu(Ⅱ) complex derived from acylhydrazone on human osteosarcoma models[J]. Inorg. Chem., 2024, 63(11): 4925-4938  doi: 10.1021/acs.inorgchem.3c04085

    30. [30]

      ZHOU F Y, GAO F X, CHANG Q H, YANG X F, LIANG L L. Three metal complexes with a pyridyl Schiff base: Cytotoxicity, migration and mechanism of apoptosis[J]. Dalton Trans., 2022, 51(39): 14993-15004  doi: 10.1039/D2DT02413F

    31. [31]

      GAO J Y, ZHANG N, HUANG D S, LIU X R, YANG Z W, ZHAO S S. Synthesis, crystal structures, CT-DNA/BSA binding modes and antibacterial activities of Zn(Ⅱ) and Cr(Ⅲ) with an acylhydrazone ligand[J]. Polyhedron, 2024, 247: 116736  doi: 10.1016/j.poly.2023.116736

    32. [32]

      CARCELLI M, FISICARO E, COMPARI C, CONTARDI L, ROGOLINO D, SOLINAS C, STEVAERT A, NAESENS L. Antiviral activity and metal ion-binding properties of some 2-hydroxy-3-methoxyphenyl acylhydrazones[J]. Biometals, 2018, 31(1): 81-89  doi: 10.1007/s10534-017-0070-6

    33. [33]

      SOCEA L I, BARBUCEANU S F, PAHONTU E M, DUMITRU A C, NITULESCU G M, SFETEA R C, APOSTOL T V. Acylhydrazones and their biological activity: A review[J]. Molecules, 2022, 27(24): 8719  doi: 10.3390/molecules27248719

    34. [34]

      BELYAEVA E R, MYASOEDOVA Y V, ISHMURATOVA N M, ISHMURATOV G Y. Synthesis and biological activity of N-acylhydrazones[J]. Russ. J. Bioorg. Chem., 2022, 48(6): 1123-1150

    35. [35]

      JAMIL I, NAWAZ F, SHAFIQ M, RASHID M, AKRAM A, SIDDIQUE A, TAIMUR S, ZAHR T. A recent trends on green synthesis and bioactivity of imidazole[J]. Univ. J. Green Chem., 2024: 50-88

    36. [36]

      GUJJARAPPA R, KABI A K, SRAVANI S, GARG A, VODNALA N, TYAGI U, KALDHI D, VELAYUTHAM R, SINGH V, GUPTA S. Overview on biological activities of imidazole derivatives[M]//SWAIN B P. Nanostructured biomaterials: Basic structures and applications. Singapore: Springer, 2022: 135-227

    37. [37]

      SAHU D, SREEKANTH P S R, BEHERA P K, PRADHAN M K, PATNAIK A, SALUNKHE S, CEP R. Advances in synthesis, medicinal properties and biomedical applications of pyridine derivatives: A comprehensive review[J]. Eur. J. Med. Chem. Rep., 2024, 12: 100210

    38. [38]

      ALLAKA T R, KATARI N K. Synthesis of pyridine derivatives for diverse biological activity profiles: A review[M]//SINGH P. Recent developments in the synthesis and applications of pyridines. Amsterdam: Elsevier, 2023: 605-625

    39. [39]

      GAO Y F, LU W, JIAN L Y, MACHATY Z, LUO H L. Vitamin E promotes ovine Sertoli cell proliferation by regulation of genes associated with cell division and the cell cycle[J]. Anim. Biotechnol., 2022, 33(2): 392-400

    40. [40]

      LI S, MU R R, GUO X Q. Defensins regulate cell cycle: Insights of defensins on cellular proliferation and division[J]. Life Sci., 2024, 349: 122740

  • 加载中
    1. [1]

      Zihe SONGJinjin ZHAONing RENJianjun ZHANG . Crystal structure, thermal analysis, and luminescence properties of six heterocyclic lanthanide complexes. Chinese Journal of Inorganic Chemistry, 2026, 42(1): 181-192. doi: 10.11862/CJIC.20250126

    2. [2]

      Yao HUANGYingshu WUZhichun BAOYue HUANGShangfeng TANGRuixue LIUYancheng LIUHong LIANG . Copper complexes of anthrahydrazone bearing pyridyl side chain: Synthesis, crystal structure, anticancer activity, and DNA binding. Chinese Journal of Inorganic Chemistry, 2025, 41(1): 213-224. doi: 10.11862/CJIC.20240359

    3. [3]

      Jia JIZhaoyang GUOWenni LEIJiawei ZHENGHaorong QINJiahong YANYinling HOUXiaoyan XINWenmin WANG . Two dinuclear Gd(Ⅲ)-based complexes constructed by a multidentate diacylhydrazone ligand: Crystal structure, magnetocaloric effect, and biological activity. Chinese Journal of Inorganic Chemistry, 2025, 41(4): 761-772. doi: 10.11862/CJIC.20240344

    4. [4]

      Yingyue ZHANGLiuqing KANGYating YANGXiaofen GUANWenmin WANG . Crystal structure and antibacterial activity of two Gd2 complexes based on polydentate Schiff-base ligands. Chinese Journal of Inorganic Chemistry, 2025, 41(9): 1867-1877. doi: 10.11862/CJIC.20250100

    5. [5]

      Wenya DINGFangfei XUJiayu GUXinran CHENKai CHEN . Synthesis and crystal structure of three cucurbit[6]uril-cadmium supramolecular assemblies. Chinese Journal of Inorganic Chemistry, 2026, 42(4): 808-816. doi: 10.11862/CJIC.20260012

    6. [6]

      Hanxue LIUShijie LIMeng RENXuling XUEHongke LIU . Design and antitumor properties of dehydroabietic acid functionalized cyclometalated iridium(Ⅲ) complex. Chinese Journal of Inorganic Chemistry, 2025, 41(8): 1483-1494. doi: 10.11862/CJIC.20250031

    7. [7]

      Lu LIUHuijie WANGHaitong WANGYing LI . Crystal structure of a two-dimensional Cd(Ⅱ) complex and its fluorescence recognition of p-nitrophenol, tetracycline, 2, 6-dichloro-4-nitroaniline. Chinese Journal of Inorganic Chemistry, 2024, 40(6): 1180-1188. doi: 10.11862/CJIC.20230489

    8. [8]

      Jiarong ZHUXiaohua ZHANGXinting XIONGXuliang NIEXiuying SONGMiaomiao ZHANGDayong PENGXiuguang YI . Crystal structure, Hirshfeld surface analysis, and antifungal activity of five complexes based on 2,5-bis(carboxymethoxy)terephthalic acid. Chinese Journal of Inorganic Chemistry, 2025, 41(11): 2358-2370. doi: 10.11862/CJIC.20250150

    9. [9]

      Lulu DONGJie LIUHua YANGYupei FUHongli LIUXiaoli CHENHuali CUILin LIUJijiang WANG . Synthesis, crystal structure, and fluorescence properties of Cd-based complex with pcu topology. Chinese Journal of Inorganic Chemistry, 2025, 41(4): 809-820. doi: 10.11862/CJIC.20240171

    10. [10]

      Xiumei LIYanju HUANGBo LIUYaru PAN . Syntheses, crystal structures, and quantum chemistry calculation of two Ni(Ⅱ) coordination polymers. Chinese Journal of Inorganic Chemistry, 2024, 40(10): 2031-2039. doi: 10.11862/CJIC.20240109

    11. [11]

      Xiumei LILinlin LIBo LIUYaru PAN . Syntheses, crystal structures, and characterizations of two cadmium(Ⅱ) coordination polymers. Chinese Journal of Inorganic Chemistry, 2025, 41(3): 613-623. doi: 10.11862/CJIC.20240273

    12. [12]

      Chao LIUJiang WUZhaolei JIN . Synthesis, crystal structures, and antibacterial activities of two zinc(Ⅱ) complexes bearing 5-phenyl-1H-pyrazole group. Chinese Journal of Inorganic Chemistry, 2024, 40(10): 1986-1994. doi: 10.11862/CJIC.20240153

    13. [13]

      Yukun CHENKexin FENGBolun ZHANGWentao SONGJianjun ZHANG . Syntheses, crystal structures, and diametrically opposed mechanically-stimulated luminescence response of two Mg(Ⅱ) metal-organic frameworks. Chinese Journal of Inorganic Chemistry, 2025, 41(6): 1227-1234. doi: 10.11862/CJIC.20240448

    14. [14]

      Yinxia SUNLiping LIUXue BAIYu SUNWanhong SUNZhepeng DENGJianghai CHENJianjun WANGLi XUShuzhen ZHANG . Synthesis and crystal structures of Co(Ⅱ)/Cu(Ⅱ) coordination polymers based on solvent and ligand concentration regulation strategy. Chinese Journal of Inorganic Chemistry, 2026, 42(2): 340-354. doi: 10.11862/CJIC.20250226

    15. [15]

      Xiaoxia WANGYa'nan GUOFeng SUChun HANLong SUN . Synthesis, structure, and electrocatalytic oxygen reduction reaction properties of metal antimony-based chalcogenide clusters. Chinese Journal of Inorganic Chemistry, 2024, 40(6): 1201-1208. doi: 10.11862/CJIC.20230478

    16. [16]

      Xiaoling WANGHongwu ZHANGDaofu LIU . Synthesis, structure, and magnetic property of a cobalt(Ⅱ) complex based on pyridyl-substituted imino nitroxide radical. Chinese Journal of Inorganic Chemistry, 2025, 41(2): 407-412. doi: 10.11862/CJIC.20240214

    17. [17]

      Yan XUSuzhi LIYan LILushun FENGWentao SUNXinxing LI . Structure variation of cadmium naphthalene-diphosphonates with the changing rigidity of N-donor auxiliary ligands. Chinese Journal of Inorganic Chemistry, 2025, 41(2): 395-406. doi: 10.11862/CJIC.20240226

    18. [18]

      Lifang HEYaoze LUOQiying SHIJianxin TANGFuxing ZHANGXiaoming ZHU . Synthesis, structure, and properties of hydrated tricyclohexyltin theophylline-7-acetic acid complex. Chinese Journal of Inorganic Chemistry, 2026, 42(3): 632-640. doi: 10.11862/CJIC.20250244

    19. [19]

      Kaimin WANGXiong GUNa DENGHongmei YUYanqin YEYulu MA . Synthesis, structure, fluorescence properties, and Hirshfeld surface analysis of three Zn(Ⅱ)/Cu(Ⅱ) complexes based on 5-(dimethylamino) isophthalic acid. Chinese Journal of Inorganic Chemistry, 2024, 40(7): 1397-1408. doi: 10.11862/CJIC.20240009

    20. [20]

      Huan ZHANGJijiang WANGGuang FANLong TANGErlin YUEChao BAIXiao WANGYuqi ZHANG . A highly stable cadmium(Ⅱ) metal-organic framework for detecting tetracycline and p-nitrophenol. Chinese Journal of Inorganic Chemistry, 2024, 40(3): 646-654. doi: 10.11862/CJIC.20230291

Metrics
  • PDF Downloads(0)
  • Abstract views(49)
  • HTML views(6)

通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Address:Zhongguancun North First Street 2,100190 Beijing, PR China Tel: +86-010-82449177-888
Powered By info@rhhz.net

/

DownLoad:  Full-Size Img  PowerPoint
Return